Wisp’s newest prescription duo tackles skin aging and low libido at once

Wisp has made its name providing fast, accessible telehealth on a direct-to-consumer model. Today, the brand is expanding its longevity offerings for women’s health with two prescriptions that target common signs of aging: skin concerns and low sexual desire. Both additions build on the Longevity and Aging category Wisp launched earlier this year, joining an existing lineup of longevity-focused products like glutathione, NAD+, and low-dose naltrexone.

What’s in the lineup

GHK-Cu topical cream at 0.5% concentration is designed to replenish a peptide that naturally declines with age. As GHK-Cu levels drop, skin tends to lose firmness and smoothness. Applied topically, it’s meant to work on that decline directly, supporting the skin’s own repair processes rather than sitting on top of it the way a standard moisturizer does.

The second product in the launch, Bremelanotide (PT-141), is a nasal spray aimed at supporting sexual desire. Wisp is known for its spray format, and for many users, it can be a much more convenient option. Most existing PT-141 options come as injectables, so a spray lowers the barrier for women who might otherwise skip treatment altogether.

Together, the two treat symptoms that don’t usually get connected to each other, even though both trace back to the same hormonal shifts happening underneath as women age.

The massive popularity of peptides has cemented them in most people’s minds as weight loss drugs. But as they get more clinical attention, it’s becoming clearer they’re relevant to a much wider range of functions. Grouping them into a lineup like this one is part of what’s shifting the conversation, treating common aging concerns like skin firmness and sexual desire not just as women’s health concerns, but as legitimate longevity concerns worth taking seriously.

Where to get it

Find out more about Wisp’s prescription care treatments at hellowisp.com.